| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 14.04 mm | 14.04 mm | 14.04 mm | 14.04 mm | 14.04 mm | 14.04 mm |
| Cash burn (monthly) | 1.79 mm | 2.65 mm | 5.07 mm | 5.30 mm | 2.62 mm | 2.91 mm |
| Cash used (since last report) | 9.06 mm | 13.41 mm | 25.68 mm | 26.82 mm | 13.28 mm | 14.74 mm |
| Cash remaining | 4.98 mm | 627.74 k | -11.64 mm | -12.78 mm | 764.45 k | -697.96 k |
| Runway (months of cash) | 2.8 | 0.2 | -2.3 | -2.4 | 0.3 | -0.2 |
| 13F holders | Current |
|---|---|
| Total holders | 15 |
| Opened positions | 5 |
| Closed positions | 13 |
| Increased positions | 0 |
| Reduced positions | 7 |
| 13F shares | Current |
|---|---|
| Total value | 1.73 bn |
| Total shares | 13.61 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Bayer Healthcare | 5.88 mm | $0.00 |
| New Enterprise Associates 15 | 4.43 mm | $0.00 |
| Joe Lonsdale | 2.54 mm | $0.00 |
| NEA Management | 442.62 k | $1.00 bn |
| ARK Investment Management | 176.67 k | $399.27 mm |
| Vanguard | 97.47 k | $220.28 mm |
| Geode Capital Management | 27.29 k | $61.69 mm |
| UBS UBS | 10.50 k | $23.72 mm |
| BlackRock | 4.00 k | $9.05 mm |
| Tower Research Capital | 2.36 k | $5.33 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | Kanya Rajangam | Common Stock | Sell | Dispose S | No | No | 4.37 | 182 | 795.34 | 8,621 |
| 6 Feb 25 | Timothy K Lu | Common Stock | Sell | Dispose S | No | No | 4.36 | 545 | 2.38 k | 82,082 |
| 4 Feb 25 | Kanya Rajangam | Common Stock | Sell | Dispose S | No | No | 4.07 | 1,297 | 5.28 k | 8,803 |
| 4 Feb 25 | Timothy K Lu | Common Stock | Sell | Dispose S | No | No | 4.07 | 3,922 | 15.96 k | 82,627 |
| 9 Dec 24 | Kanya Rajangam | Common Stock Warrant Common Stock | Grant | Acquire A | Yes | No | 2.3 | 49,500 | 113.85 k | 49,500 |
| 9 Dec 24 | Kanya Rajangam | Series A Convertible Preferred Stock Common Stock | Grant | Acquire A | Yes | No | 2250 | 33 | 74.25 k | 33 |
